107 related articles for article (PubMed ID: 16361157)
1. [bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion].
Zheng JM; Wang DK; Jiang HM
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1537-9. PubMed ID: 16361157
[TBL] [Abstract][Full Text] [Related]
2. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
Ali MA; Rosati R; Pettit GR; Kalemkerian GP
Anticancer Res; 1998; 18(2A):1021-6. PubMed ID: 9615758
[TBL] [Abstract][Full Text] [Related]
3. Cellular models of drug- and radiation-resistant small cell lung cancer.
Davey RA; Locke VL; Henness S; Harvie RM; Davey MW
Anticancer Res; 2004; 24(2A):465-71. PubMed ID: 15152945
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a novel bis-aziridinylnaphthoquinone (AZ4) mediating cell cycle arrest and apoptosis in non-small cell lung cancer cell line NCI-H460.
Shyu KG; Huang ST; Kuo HS; Cheng WP; Lin YL
Acta Pharmacol Sin; 2007 Apr; 28(4):559-66. PubMed ID: 17376296
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
He DM; Zhang H
Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
[TBL] [Abstract][Full Text] [Related]
7. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
8. Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells.
Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Tanimoto M
Oncol Rep; 2006 Mar; 15(3):571-6. PubMed ID: 16465414
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A
Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365
[TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer.
Kalemkerian GP; Jasti RK; Celano P; Nelkin BD; Mabry M
Cell Growth Differ; 1994 Jan; 5(1):55-60. PubMed ID: 8123593
[TBL] [Abstract][Full Text] [Related]
11. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line.
Walker C; Wright-Perkins S
Oncol Res; 1992; 4(10):419-29. PubMed ID: 1337994
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030
[TBL] [Abstract][Full Text] [Related]
13. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification.
Kalemkerian GP; Ou X; Adil MR; Rosati R; Khoulani MM; Madan SK; Pettit GR
Cancer Chemother Pharmacol; 1999; 43(6):507-15. PubMed ID: 10321512
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the aberrant expression of a paraneoplastic antigen, recoverin, in small cell lung cancer cell lines.
Bazhin AV; Savchenko MS; Belousov EV; Jaques G; Philippov PP
Lung Cancer; 2004 Sep; 45(3):299-305. PubMed ID: 15301870
[TBL] [Abstract][Full Text] [Related]
15. Oblimersen sodium (Genasense bcl-2 antisense oligonucleotide): a rational therapeutic to enhance apoptosis in therapy of lung cancer.
Herbst RS; Frankel SR
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4245s-4248s. PubMed ID: 15217967
[TBL] [Abstract][Full Text] [Related]
16. Effects of emodin on gene expression profile in small cell lung cancer NCI-H446 cells.
Fu ZY; Han JX; Huang HY
Chin Med J (Engl); 2007 Oct; 120(19):1710-5. PubMed ID: 17935676
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response.
Loriot Y; Mordant P; Brown BD; Bourhis J; Soria JC; Deutsch E
Anticancer Res; 2010 Oct; 30(10):3869-78. PubMed ID: 21036697
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
19. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis.
Harada N; Maniwa Y; Yoshimura M; Nagata M; Hamada H; Yokono K; Okita Y
Oncol Rep; 2005 Nov; 14(5):1155-63. PubMed ID: 16211279
[TBL] [Abstract][Full Text] [Related]
20. Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells.
Kuhar M; Sen S; Singh N
Anticancer Res; 2006; 26(2A):1297-303. PubMed ID: 16619537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]